Schedule:
TIME |
Focus Discussion Topic |
Moderator |
*3 Groups in Parallel discussing Topic #1 | ||
1:15 - 2:45 |
Topic 1: Perceived challenges with FDA/EU/other Regulatory review questions as well as PAIs |
Joint FDA/Industry |
2:45 - 4:15 |
Topic 2: Applicability of Continuous Manufacturing to a Diverse Pharmaceutical Portfolio |
Lilly |
2:45 - 4:15 |
Topic 3: Experience and Technical Capability of Staff to Implement Continuous Manufacturing |
GSK |
2:15 - 4:15 |
Topic 4: Needed Equipment and Associated Facility Cost |
Pfizer |